J05: Antivirals for systemic use
Published
May 5, 2025
Under construction
| J05 | ANTIVIRALS FOR SYSTEMIC USE |
|---|---|
| J05A | DIRECT ACTING ANTIVIRALS |
| J05AA | Thiosemicarbazones |
| J05AB | Nucleosides and nucleotides excl. reverse transcriptase inhibitors |
| J05AC | Cyclic amines |
| J05AD | Phosphonic acid derivatives |
| J05AE | Protease inhibitors |
| J05AF | Nucleoside and nucleotide reverse transcriptase inhibitors |
| J05AG | Non-nucleoside reverse transcriptase inhibitors |
| J05AH | Neuraminidase inhibitors |
| J05AJ | Integrase inhibitors |
| J05AP | Antivirals for treatment of HCV infections |
| J05AR | Antivirals for treatment of HIV infections, combinations |
| J05AX | Other antivirals |